Skip to main content

Table 3 Severity of biopsy- related bleeding*

From: Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease – a prospective, randomized, multicentre cross-over trial

TBCB N = 359 (100%)

Bleeding– no. (%)

None

98 (27.3)

Mild

203 (56.5)

Moderate

54 (15.0)

Severe

4 (1.1)

TBFB N = 359 (100%)

 None 186 (51.8)

82 (22.8)

88 (24.5)

14 (3.9)

2 (0.6)

 Mild 158 (44.0)

14 (3.9)

111 (30.9)

31 (8.6)

2 (0.6)

 Moderate 15 (4.2)

2 (0.6)

4 (1.1)

9 (2.5)

0 (0)

 Severe 0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

  1. Severity of biopsy-related bleeding, comparing both techniques (TBCB – transbronchial lung cryobiopsy; TBFB – transbronchial lung forceps biopsy) for each patient. Severity of bleeding was categorized as no, mild, moderate and severe bleeding as defined above. Difference in bleeding incidence was significant different over all categories (*p < 0.001, calculated by the Bowker’s test)